[Nitroblue tetrazolium (NBT) test as a potential diagnostic aid in the preoperative detection of patients at risk for infection].
The clinical application of a simple quantitative NBT-test to investigate the "killing function" of granulocytes in surgical patients with various underlying diseases is described. In this test preoperative patients showing a decreased NBT-reduction in their leucocytes always developed infectious complications after surgery. Taken together, these results indicate that the NBT-test could be used as a "simple indicator" of the granulocyte function in respect to the predictability for patients with high risk of infection.
D000368:Aged; D005260:Female; D005767:Gastrointestinal Diseases / Q000601:surgery; D006098:Granulocytes / Q000276:immunology*; D006801:Humans; D008107:Liver Diseases / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009580:Nitroblue Tetrazolium; D010587:Phagocytosis; D012306:Risk; D013530:Surgical Wound Infection / Q000175:diagnosis* / Q000276:immunology; D013778:Tetrazolium Salts
D013778:Tetrazolium Salts; D009580:Nitroblue Tetrazolium
Der Nitroblau-Tetrazolium (NBT)-Test als potentiell diagnostisches Hilfsmittel zur präoperativen Erfassung infektionsgefährdeter Patienten.